Thoma Bravo, a leading private equity firm with a strong focus on software and technology, has announced its acquisition of Verint Systems in a $2 billion all-cash deal, signaling a major consolidation in the customer experience (CX) technology space. The move will bring Verint together with Thoma Bravo’s existing investment, Calabrio, to form a unified AI-driven CX powerhouse expected to reshape the $50 billion market for customer experience automation solutions. The transaction is expected to close in early 2026, pending regulatory approvals and customary closing conditions.
The combination of Verint and Calabrio will create a broad, integrated platform for organizations seeking to optimize their customer engagement strategies. Both companies bring complementary technologies and expertise, covering workforce optimization, agent engagement, and business intelligence solutions. The merger is aimed at enabling businesses of all sizes to accelerate outcomes in customer interactions, leveraging artificial intelligence to drive insights, operational efficiencies, and improved service delivery. By uniting their platforms, the combined company will offer a wider array of tools for automating and analyzing customer touchpoints, from call centers to digital channels.
Calabrio’s cloud-native suite, Calabrio ONE, already provides workforce performance management, AI-powered analytics, and personalized coaching capabilities, helping organizations maximize agent effectiveness and enhance customer satisfaction. Verint adds robust analytics, AI-driven interaction management, and workflow automation, strengthening the combined company’s ability to serve complex, enterprise-scale clients. Together, the companies are positioned to deliver the most comprehensive CX platform in the industry, appealing to both mid-market and large enterprises that prioritize efficiency, responsiveness, and customer loyalty.
Thoma Bravo’s investment reflects its long-standing commitment to growth and innovation in the software sector. With over $184 billion in assets under management and a track record of acquiring or investing in more than 500 companies over two decades, the firm aims to leverage its operational expertise to accelerate the development of Verint and Calabrio’s combined offerings. The strategic goal is to not only enhance the companies’ technological capabilities but also expand their reach across global markets, helping brands harness AI and data-driven insights to transform customer experiences.
Industry analysts expect the merger to bring immediate benefits to existing customers by streamlining product portfolios and integrating best practices from both companies. Calabrio and Verint are committed to maintaining and investing in their existing solutions, ensuring continuity for current clients while offering access to new, AI-enabled capabilities. The unified company is also expected to foster innovation through expanded research and development efforts, creating opportunities for next-generation CX solutions and strengthening its competitive position in a fast-evolving market.
Overall, the acquisition marks a significant step in the ongoing consolidation of the CX technology landscape, emphasizing the increasing role of AI in driving operational efficiencies and business outcomes. By combining Verint’s and Calabrio’s expertise, Thoma Bravo is poised to create a dominant player capable of shaping the future of customer experience management globally.
Toronto, Ontario–(Newsfile Corp. – August 21, 2025) – Aurania Resources Ltd. (TSXV: ARU) (OTCQB: AUIAF) (FSE: 20Q) (“Aurania” or the “Company”) announces that further to its news releases dated August 1, 2025 and August 5, 2025, the Company has closed an oversubscribed non-brokered private placement financing (the “Offering“). Total gross proceeds of C$1,906,355.76 were raised through the issuance of 15,886,298 units of the Company (the “Units“) at a price of C$0.12 per Unit.
Each Unit is composed of one common share of the Company (a “Common Share“) and one Common Share purchase warrant (a “Warrant“). Each Warrant entitles the holder to purchase one Common Share (a “Warrant Share“) at an exercise price of C$0.25 for a period of 24 months following the closing of the date of issuance.
In connection with the Offering, the Company paid aggregate finder’s fees consisting of (i) C$5118.40 in cash (the “Cash Consideration“) and (ii) 42,653 compensation warrants (the “Compensation Warrants”) to eligible finders. Each Compensation Warrant entitles the holder to acquire one additional Unit at a price of C$0.12 per Unit for a period of 24 months from the date of issuance. Each Unit issuable upon exercise of a Compensation Warrant is comprised of one Common Share and one Warrant. Each such Warrant entitles the holder to acquire one Warrant Share at a price of C$0.25 per Warrant Share for a period of 24 months from the date of issuance of the Compensation Warrant.
The Company intends to use the net proceeds from the Offering primarily for exploration programs, general working capital purposes, and a portion of the proceeds will be allocated for the first payment of 2025 mineral concession fees in Ecuador.
The closing of the Offering is subject to the receipt of all necessary regulatory approvals, including the final approval of the TSX Venture Exchange. All securities issued and issuable pursuant to the Offering are subject to a four-month plus one day hold period commencing on the date of issuance.
Related Party Transactions Dr. Keith Barron, CEO and a director of the Company, acquired 5,741,666 Units under the Offering (the “Acquisition“). The Acquisition constitutes a “related party transaction” as defined under the policies of the TSXV and Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101“). The Company is relying on exemptions from the minority shareholder approval and formal valuation requirements applicable to the related party transactions under sections 5.5(a) and 5.7(1)(a), respectively, of MI 61-101, as the fair market value of the Acquisition does not exceed 25 percent of the Company’s market capitalization.
The securities described herein have not been, and will not be, registered under the United States Securities Act, or any state securities laws, and accordingly may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.
About Aurania Aurania is a mineral exploration company engaged in the identification, evaluation, acquisition, and exploration of mineral property interests, with a focus on precious metals and copper in South America. Its flagship asset, The Lost Cities – Cutucu Project, is located in the Jurassic Metallogenic Belt in the eastern foothills of the Andes mountain range of southeastern Ecuador.
The Biden-era CHIPS Act was designed to revive America’s semiconductor sector, but under the Trump administration, that funding is taking a new form: direct equity ownership. On Friday, President Trump announced that the U.S. government will acquire a 10% stake in Intel, a move aimed at stabilizing the struggling chipmaker and cementing its role in America’s technology future.
The announcement sparked immediate investor reaction, sending Intel shares up more than 7% in midday trading. The move represents one of the most aggressive interventions in U.S. industrial policy in recent years, underscoring Washington’s belief that semiconductors are not only an economic priority but also a national security imperative.
Intel has endured a turbulent few years. Once the undisputed leader in computer processors, the company has seen its dominance erode as rivals Advanced Micro Devices and Qualcomm gained ground in the PC market. Meanwhile, Nvidia has surged ahead in artificial intelligence chips, leaving Intel far behind in one of the fastest-growing and most strategically critical corners of the tech world.
Financially, the company has struggled to contain mounting losses. Its manufacturing division continues to bleed cash, while its market capitalization of roughly $111 billion is less than half of what it was in 2021. Under current CEO Lip-Bu Tan, Intel has been forced to make difficult cuts, laying off 15% of its workforce and shelving ambitious international expansion plans, including new facilities in Europe.
Still, Intel holds unique strategic importance. It remains the only U.S.-based company capable of producing advanced semiconductors at scale, a capability that has become increasingly vital as the global chip supply chain faces geopolitical risks. With tensions between the U.S. and China intensifying, reshoring semiconductor manufacturing has become a bipartisan priority in Washington.
Trump’s announcement also comes just days after Japan’s SoftBank Group revealed a $2 billion investment in Intel, signaling international confidence that the company may yet succeed in its turnaround. Even so, the road ahead remains challenging. Intel’s $20 billion Ohio chip complex—once heralded as the centerpiece of America’s semiconductor revival—has been delayed again, reflecting the company’s struggle to balance ambition with financial discipline.
At the same time, Intel is trying to reinvent itself as a contract chip manufacturer, or foundry, capable of producing semiconductors for other firms. Microsoft and Amazon have already signed agreements to use Intel’s newest 18A chip technology, but Intel itself remains its largest foundry customer, raising questions about whether it can truly scale the business to rival Taiwan Semiconductor Manufacturing Company (TSMC).
The U.S. government’s decision to become a shareholder in Intel adds a new layer of complexity. Supporters argue it provides Intel with the financial stability and political backing it needs to remain competitive in a cutthroat industry. Critics, however, caution that government ownership could distort market dynamics and discourage private-sector innovation.
For now, markets appear optimistic. Intel’s rally suggests investors see Washington’s stake as a sign of long-term commitment to keeping the company afloat. With global demand for chips set to surge alongside artificial intelligence, electric vehicles, and cloud computing, Intel’s future may hinge on whether government backing can help it reclaim its leadership position in one of the world’s most consequential industries.
Patrick McCann, CFA, Research Analyst, Noble Capital Markets, Inc.
Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Fiscal Q4 beat. SelectQuote posted Q4 revenue of $345.1 million and adj. EBITDA of $2.7 million, beating expectations. Agent productivity improved with AI integration and workflow streamlining. The company navigated Medicare enrollment headwinds by reallocating resources efficiently, demonstrating continued operating discipline across its core platform.
SelectRx paying off. Healthcare Services revenue rose 49% year-over-year to $210.6 million with membership hitting 108,000, up from 82,000 the year prior. Notably segment adj. EBITDA margins of 5.5% are expected to improve throughout fiscal 2026 based on efficiency gains from the Kansas facility and customer maturity.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Accelerated warrant exercise. Nicola Mining Inc. (TSX.V: NIM, OTCQB: HUSIF, FSE: HLIA) reported the accelerated exercise of 2,019,477 share purchase warrants at C$0.40 each, generating C$807,791 in gross proceeds. On July 21, Nicola Mining announced that it was electing to accelerate the expiry of all the outstanding common share purchase warrants originally issued under a financing that closed in March 2025.
Merritt Mill is ramping up production. With 200 tonnes per day of capacity, Nicola’s Merritt Mill is transitioning to full commercial production and cash flow generation. Nicola expects to utilize 100% of the mill’s capacity by the end of the third quarter. In early July, the Merritt Mill began processing ore received from Talisker Resources’ Bralorne project. In addition to processing ore for Talisker, ore is expected to be received during the third quarter from Blue Lagoon’s Dome Mountain gold mine, and from the Dominion Creek Gold Project, of which Nicola owns a 75% economic interest. Cash milling margins of 15% to 18% are expected at full capacity.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Oversubscribed private placement. Aurania raised gross proceeds of C$1,906,355.76 with the issuance of 15,886,298 units at C$0.12 per unit. Each unit is composed of one common share and one common share purchase warrant that entitles the holder to purchase one common share at an exercise price of C$0.25 for 24 months following the date of issuance. Dr. Keith Barron, CEO and director, acquired 5,741,666 units during the offering.
Use of proceeds. Aurania intends to use the net proceeds primarily for exploration programs and general working capital purposes. In our view, the oversubscribed private placement significantly enhances the company’s financial flexibility.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
ISAP RFP. In a somewhat surprising development, Immigration and Customs Enforcement has issued a request for proposals for the fifth iteration of its Intensive Supervision Appearance Program (ISAP), with a plan to award a potential $2 billion indefinite-delivery/indefinite-quantity contract. Consensus expectations were that an RFP would be released more towards the end of 2025.
Details. The contract will have a maximum performance period of two years, divided into two one-year ordering periods, a significant change from the prior 5-year performance periods. Responses are due by September 1st, a much shorter period than the 6 weeks from the 2019 contract. The contract is scheduled to begin on October 1, 2025.
Best Value. Bids will be measured on the Best Value Trade-off principle, with the three evaluation factors being, in terms of importance, (i) prior experience, (ii) technical scenarios, and (iii) price. Prior experience and technical scenarios will be significantly more important than price.
Implication. The $2 billion max award over a two-year period suggests ICE is expecting a significant increase in the number of ISAP participants. We would note that in 2024 GEO, the long-time holder of the ISAP contract, generated approximately $330 million of revenue in its Electronic Monitoring and Supervision Services segment, at a time when the average population was roughly 185,000.
Thoughts. The short response period, 2-year period of performance, and Best Value Trade-off principle would all appear to favor the incumbent contract holder, in this case, GEO, in our opinion. We are somewhat surprised ICE is not seeking multiple awardees, although the relatively short nature of this award may reflect a stop gap to enable ICE to figure out any complexities of having multiple awardees.
Research reports on companies mentioned in this report are available by clicking below:
All statements or opinions contained herein that include the words “we”, “us”, or “our” are solely the responsibility of Noble Capital Markets, Inc.(“Noble”) and do not necessarily reflect statements or opinions expressed by any person or party affiliated with the company mentioned in this report. Any opinions expressed herein are subject to change without notice. All information provided herein is based on public and non-public information believed to be accurate and reliable, but is not necessarily complete and cannot be guaranteed. No judgment is hereby expressed or should be implied as to the suitability of any security described herein for any specific investor or any specific investment portfolio. The decision to undertake any investment regarding the security mentioned herein should be made by each reader of this publication based on its own appraisal of the implications and risks of such decision.
This publication is intended for information purposes only and shall not constitute an offer to buy/sell or the solicitation of an offer to buy/sell any security mentioned in this report, nor shall there be any sale of the security herein in any state or domicile in which said offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or domicile. This publication and all information, comments, statements or opinions contained or expressed herein are applicable only as of the date of this publication and subject to change without prior notice. Past performance is not indicative of future results. Noble accepts no liability for loss arising from the use of the material in this report, except that this exclusion of liability does not apply to the extent that such liability arises under specific statutes or regulations applicable to Noble. This report is not to be relied upon as a substitute for the exercising of independent judgement. Noble may have published, and may in the future publish, other research reports that are inconsistent with, and reach different conclusions from, the information provided in this report. Noble is under no obligation to bring to the attention of any recipient of this report, any past or future reports. Investors should only consider this report as single factor in making an investment decision.
IMPORTANT DISCLOSURES
This publication is confidential for the information of the addressee only and may not be reproduced in whole or in part, copies circulated, or discussed to another party, without the written consent of Noble Capital Markets, Inc. (“Noble”). Noble seeks to update its research as appropriate, but may be unable to do so based upon various regulatory constraints. Research reports are not published at regular intervals; publication times and dates are based upon the analyst’s judgement. Noble professionals including traders, salespeople and investment bankers may provide written or oral market commentary, or discuss trading strategies to Noble clients and the Noble proprietary trading desk that reflect opinions that are contrary to the opinions expressed in this research report. The majority of companies that Noble follows are emerging growth companies. Securities in these companies involve a higher degree of risk and more volatility than the securities of more established companies. The securities discussed in Noble research reports may not be suitable for some investors and as such, investors must take extra care and make their own determination of the appropriateness of an investment based upon risk tolerance, investment objectives and financial status.
Company Specific Disclosures
The following disclosures relate to relationships between Noble and the company (the “Company”) covered by the Noble Research Division and referred to in this research report. Noble is not a market maker in any of the companies mentioned in this report. Noble intends to seek compensation for investment banking services and non-investment banking services (securities and non-securities related) with any or all of the companies mentioned in this report within the next 3 months
ANALYST CREDENTIALS, PROFESSIONAL DESIGNATIONS, AND EXPERIENCE
Senior Equity Analyst focusing on Basic Materials & Mining. 20 years of experience in equity research. BA in Business Administration from Westminster College. MBA with a Finance concentration from the University of Missouri. MA in International Affairs from Washington University in St. Louis. Named WSJ ‘Best on the Street’ Analyst and Forbes/StarMine’s “Best Brokerage Analyst.” FINRA licenses 7, 24, 63, 87
WARNING
This report is intended to provide general securities advice, and does not purport to make any recommendation that any securities transaction is appropriate for any recipient particular investment objectives, financial situation or particular needs. Prior to making any investment decision, recipients should assess, or seek advice from their advisors, on whether any relevant part of this report is appropriate to their individual circumstances. If a recipient was referred to Noble Capital Markets, Inc. by an investment advisor, that advisor may receive a benefit in respect of transactions effected on the recipients behalf, details of which will be available on request in regard to a transaction that involves a personalized securities recommendation. Additional risks associated with the security mentioned in this report that might impede achievement of the target can be found in its initial report issued by Noble Capital Markets, Inc.. This report may not be reproduced, distributed or published for any purpose unless authorized by Noble Capital Markets, Inc..
RESEARCH ANALYST CERTIFICATION
Independence Of View All views expressed in this report accurately reflect my personal views about the subject securities or issuers.
Receipt of Compensation No part of my compensation was, is, or will be directly or indirectly related to any specific recommendations or views expressed in the public appearance and/or research report.
Ownership and Material Conflicts of Interest Neither I nor anybody in my household has a financial interest in the securities of the subject company or any other company mentioned in this report.
The Trump administration is weighing whether to divert at least $2 billion from the CHIPS and Science Act toward U.S. critical minerals projects, according to people familiar with the deliberations. The move would mark a significant redirection of funds originally earmarked for semiconductor research and factory construction, underscoring the White House’s push to reduce reliance on China for strategic resources.
The CHIPS Act, signed into law in 2022 under President Joe Biden, was designed to strengthen domestic semiconductor manufacturing and research through more than $50 billion in incentives. Since taking office in January, President Trump has repeatedly criticized the law as an overly generous “corporate giveaway” and has sought to reshape its provisions. Redirecting funds toward mining and mineral processing would be one of his most consequential adjustments yet.
Supporters of the potential shift argue that the proposal is consistent with the CHIPS Act’s core mission: ensuring secure and stable supply chains for chipmaking. Semiconductor fabrication requires a steady flow of critical materials such as gallium, germanium, and rare earth elements, areas where China dominates global production and processing.
“The administration is creatively trying to find ways to fund the critical minerals sector,” one source said, noting that any changes remain under discussion.
Commerce Secretary Howard Lutnick, a former Wall Street executive tapped by Trump earlier this year, would gain expanded authority over funding decisions. His office already manages CHIPS Act disbursements but would now oversee a broader portfolio of projects spanning mining, processing, and recycling. The move follows internal tensions after the Pentagon’s recent investment in rare earths producer MP Materials raised questions about Washington’s broader minerals strategy.
For U.S. mining and processing firms, the potential reallocation could provide a much-needed financial lifeline. Companies such as Albemarle, the world’s largest lithium producer, have warned that stalled U.S. refinery projects will be difficult to revive without direct government support. Similar challenges face smaller recycling and processing ventures, many of which struggle to compete with China’s state-backed operations.
It remains unclear whether the administration would deploy the $2 billion as grants, loans, or equity stakes. Lutnick has reportedly pushed to “get the money out the door” quickly, signaling urgency in expanding domestic mineral capacity. Additional funding reallocations may follow if the strategy is adopted.
The Biden administration previously considered using CHIPS Act dollars for critical minerals but dismissed the idea as uneconomical and environmentally complex. Critics of Trump’s approach may raise similar concerns, pointing to the permitting hurdles and potential environmental impacts of new mining operations. Others warn that shifting money away from semiconductor projects could weaken efforts to bring advanced chip manufacturing back to U.S. soil.
Still, Trump has moved aggressively to boost resource production. He has signed executive orders promoting deep-sea mining and met with major industry leaders, including Rio Tinto and BHP executives, to highlight his commitment. The administration’s broader strategy is also being coordinated with the Department of Energy, which last week proposed $1 billion in critical minerals spending tied to infrastructure legislation.
By elevating Lutnick’s role, the White House seeks to consolidate decision-making and avoid the fragmented approach seen earlier this summer. Administration officials say this shift will create clearer guidelines for government support across the minerals sector, though questions remain about how conflicts of interest will be managed.
The deliberations highlight the administration’s view that secure mineral supply chains are as vital as semiconductor fabs themselves. Whether Congress and industry stakeholders embrace the reallocation will determine how far the plan advances — and how quickly Washington can build resilience in two sectors that underpin the nation’s technological and economic future.
Markets are experiencing a rare moment in financial history. Nearly every major benchmark or asset class is sitting at record levels — from the Dow Jones and Nasdaq to gold, Bitcoin, housing values, rents, IPOs, and merger activity. Even the U.S. national debt has climbed to historic highs. The only notable exception is the Russell 2000 small-cap index, which has lagged behind its larger-cap peers.
This convergence of highs across so many areas raises critical questions: Is this sustainable, and where should investors look next?
At the heart of the rally is anticipation. Inflation has eased enough for Wall Street to believe the Federal Reserve will begin cutting interest rates in the coming months. Markets tend to price in expectations before policy changes occur, which explains why equities, real estate, and digital assets have surged despite borrowing costs still being elevated.
Corporate strength is also contributing. Tech giants continue to deliver outsized earnings, fueling growth in the Nasdaq, while strong balance sheets across industries are powering mergers and acquisitions at a record pace. Investors aren’t just chasing momentum; they’re betting on resilient fundamentals.
Interestingly, the surge is not limited to risk assets. Gold and Bitcoin, often viewed as hedges against uncertainty, have also reached record highs. That signals investors are not fully comfortable with the backdrop of ballooning U.S. debt, currency volatility, and geopolitical tensions.
In short, markets are climbing on optimism — but they’re also hedging.
The biggest challenge is valuation. Equities trading at record levels are vulnerable if earnings slow or if rate cuts fail to materialize. Housing markets, while supported by supply shortages, remain stretched on affordability. IPOs and M&A often peak late in a cycle, suggesting companies may be capitalizing on favorable conditions before they shift.
The Federal Reserve is the wild card. If policymakers cut rates in September as many expect, small-cap stocks — represented by the Russell 2000 — could see sharp gains. These companies are more sensitive to borrowing costs and have lagged during the tightening cycle. Conversely, if the Fed holds rates steady or signals fewer cuts, markets could face a correction.
Where Investors Should Look
Given the uncertainty, balance is essential. Investors might consider:
Small Caps (Russell 2000): The one major index not at record highs, offering upside potential if rates decline.
Defensive Dividend Stocks: Companies with consistent cash flow in healthcare, consumer staples, and utilities provide resilience.
Gold and Bitcoin: Effective hedges amid debt concerns and potential dollar weakness.
Global Diversification: International markets, many of which trade at lower valuations, offer opportunity.
Cash and Treasuries: With attractive short-term yields, keeping dry powder for potential volatility makes sense.
Markets are in uncharted territory, with nearly everything at record highs. Optimism about rate cuts and earnings strength is driving the surge, but stretched valuations and policy uncertainty suggest caution. Investors who balance growth exposure with hedges and defensive positions may be best positioned for what comes next.
DENVER–(BUSINESS WIRE)–Veritone (NASDAQ: VERI), a leader in human-centered enterprise AI solutions, today announced a new partnership with Newsmax, one of America’s leading news networks. This collaboration will bring Veritone’s advanced Digital Media Hub (DMH) technology and licensing expertise to Newsmax, enabling it to modernize its newsroom production workflows and unlock the value of its 20-year content archive.
Veritone’s DMH application, powered by its aiWARE™ platform, will enable Newsmax to fully search and utilize its vast library of content – a resource that is increasingly valuable in today’s high-demand media landscape. With Newsmax broadcasts running 24/7 and a continually expanding library of content, the newsroom’s ability to make this material searchable and globally accessible is vital for responding to the evolving needs of both Newsmax viewers and business partners.
“This partnership marks a pivotal chapter for Newsmax’s operational and commercial strategy,” said Sean King, Chief Revenue Officer and General Manager of Veritone Commercial. “By leveraging the capabilities of DMH and our licensing solutions, Newsmax can turn its archive into a dynamic asset, fueling audience engagement and revenue growth.”
Newsmax’s expansive archive offers unparalleled opportunities for monetization. Leveraging the expertise of Veritone’s licensing team and AI-powered solutions, Newsmax now has the tools and support to transform its content into new revenue streams, ensuring that its content is accessible to audiences of all kinds, enabling a broader and more impactful reach.
This collaboration underscores Veritone’s commitment to empowering media organizations with cutting-edge AI solutions that streamline operations and maximize content potential, which is needed more now than ever as the media landscape continues to undergo rapid digital transformation.
About Veritone Veritone (NASDAQ: VERI) builds human-centered enterprise AI solutions. Serving customers in the media, entertainment, public sector and talent acquisition industries, Veritone’s software and services empower individuals at the world’s largest and most recognizable brands to run more efficiently, accelerate decision making and increase profitability. Veritone’s leading enterprise AI platform, aiWARE™, orchestrates an ever-growing ecosystem of machine learning models, transforming data sources into actionable intelligence. By blending human expertise with AI technology, Veritone advances human potential to help organizations solve problems and achieve more than ever before, enhancing lives everywhere. To learn more, visit Veritone.com.
Recognition Highlights Bitcoin Depot’s Impact and Commitment to Delivering Accessible, Secure, and Convenient Bitcoin Access Nationwide
ATLANTA, Aug. 21, 2025 (GLOBE NEWSWIRE) — Bitcoin Depot (“Bitcoin Depot” or the “Company”) (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced that it has been recognized as one of America’s Greatest Companies 2025 by Newsweek and Plant-A Insights Group.
The annual list celebrates companies that excel in employee satisfaction, customer experience, and long-term business growth. Newsweek’s evaluation process included employee interviews, customer surveys, publicly available performance data, and more than 120 key performance indicators.
“Being recognized among America’s Greatest Companies is a testament to our team’s unwavering focus on delivering value to our customers while fostering a workplace where our employees can thrive,” said Brandon Mintz, CEO and founder of Bitcoin Depot. “Our mission has always been to make crypto accessible to everyone, and we are proud to be recognized for both our business achievements and our commitment to our people.”
Bitcoin Depot operates more than 9,000 BTMs across North America and Australia, enabling customers to seamlessly convert cash into Bitcoin for payments, transfers, remittances, and investments. The recognition comes during a landmark year of growth for the Company, which recently reported strong Q2 2025 results, announced multiple strategic partnerships and acquisitions, added Bitcoin to its treasury, and expanded its leadership team.
“A great workplace is one that strives to make all its employees feel respected and appreciated,” said Newsweek Editor-in-Chief Jennifer H. Cunningham. “But ensuring that employees are comfortable and valued is something only some companies excel at.”
This honor highlights how Bitcoin Depot’s cash-to-crypto approach is reshaping access to digital assets and strengthening its position as an industry leader.
About Bitcoin Depot Bitcoin Depot Inc. (Nasdaq: BTM) was founded in 2016 with the mission to connect those who prefer to use cash to the broader, digital financial system. Bitcoin Depot provides its users with simple, efficient and intuitive means of converting cash into Bitcoin, which users can deploy in the payments, spending and investing space. Users can convert cash to bitcoin at Bitcoin Depot kiosks in 47 states and at thousands of name-brand retail locations in 31 states through its BDCheckout product. The Company has the largest market share in North America with over 9,000 kiosk locations as of June 2025. Learn more at www.bitcoindepot.com.
U.S. home sales showed signs of renewed momentum in July, offering a glimmer of relief for buyers and sellers navigating one of the tightest housing markets in years. According to data from the National Association of Realtors, sales of previously owned homes increased 2% from June to a seasonally adjusted annual rate of 4.01 million units. That figure also marked a 0.8% gain compared with July 2024, defying expectations of a modest decline.
The pickup in activity reflects contracts that were signed earlier in the summer, when mortgage rates began to edge down from their spring highs. The average 30-year fixed mortgage briefly exceeded 7% in May but had retreated to around 6.67% by the end of June. That shift helped unlock demand from buyers who had been sidelined by affordability challenges.
At the same time, supply conditions continued to improve. The number of homes available for sale at the end of July climbed to 1.55 million, up nearly 16% from a year ago. That level represents a 4.6-month supply at the current sales pace, the highest since May 2020 but still short of the six-month threshold considered a balanced market. For prospective buyers, the increase in inventory has translated into more choice and slightly less upward pressure on prices.
Even so, home values remain stubbornly high. The median price of an existing home sold in July reached $422,400, a record for the month and 0.2% higher than a year earlier. That marked the 25th consecutive month of annual price gains, underscoring how persistent demand and limited long-term supply continue to shape the market. Still, with wage growth now outpacing home price appreciation in some regions, economists suggest the market could be approaching an inflection point where affordability begins to improve.
Regional and price-segment dynamics reveal additional shifts. Sales activity has been strongest at the higher end of the market, with transactions on homes priced above $1 million jumping more than 7% from a year ago. In contrast, sales of properties priced below $250,000 remained flat or declined, squeezed by limited availability and still-elevated borrowing costs. In the South, where condominium prices have fallen over the past year, demand for that segment showed particular resilience.
Market behavior also reflects growing participation from investors and cash buyers. Investors accounted for 20% of transactions in July, up sharply from 13% a year earlier, likely taking advantage of the increased supply. Meanwhile, 31% of sales were completed with all cash, compared with 27% last July. That unusually high share suggests that wealth from equities and housing gains is playing a greater role in the market.
Homes are also taking longer to sell. The typical property stayed on the market for 28 days in July, compared with 24 days a year ago. First-time buyers accounted for just 28% of sales, slipping from both June and the same month last year, reflecting the ongoing affordability strain at the entry level of the market.
Overall, July’s data points to a housing sector that is slowly recalibrating. Rising inventory and moderating mortgage rates are offering incremental relief, yet prices remain elevated, and demand is concentrated in higher price tiers. Whether the market has reached a true turning point may depend on the Federal Reserve’s next moves on interest rates and how quickly supply can return to more balanced levels.
Fourth Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights
Revenue of $345.1 million
Net income of $12.9 million
Adjusted EBITDA* of $2.7 million
Fiscal Year 2026 Guidance Ranges:
Revenue expected in a range of $1.650 billion to $1.750 billion
Adjusted EBITDA* expected in a range of $120 million to $150 million
Fourth Quarter Fiscal Year 2025 – Segment Highlights
Senior
Revenue of $82.5 million
Adjusted EBITDA* of $7.7 million
Approved Medicare Advantage policies of 85,344
Healthcare Services
Revenue of $214.0 million
Adjusted EBITDA* of $11.9 million
108,018 SelectRx members
Life
Revenue of $48.0 million
Adjusted EBITDA* of $6.9 million
OVERLAND PARK, Kan.–(BUSINESS WIRE)– This press release is to correct and replace the previously issued press release to reflect the following:
On the Consolidated Statements of Comprehensive Income (Loss) for the three-month period ending June 30, 2025, the amount reported for the Selling, general and administrative line item is $41,591,000 and for the Technical development line item it is $9,594,000. In the prior version of the press release, these amounts were inadvertently transposed on the Consolidated Statements of Comprehensive Income (Loss). The correction has no impact on the reported Net Income or Adjusted EBITDA for the period presented.
The updated release reads:
SELECTQUOTE, INC. REPORTS FOURTH QUARTER OF FISCAL YEAR 2025 RESULTS
Fourth Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights
Revenue of $345.1 million
Net income of $12.9 million
Adjusted EBITDA* of $2.7 million
Fiscal Year 2026 Guidance Ranges:
Revenue expected in a range of $1.650 billion to $1.750 billion
Adjusted EBITDA* expected in a range of $120 million to $150 million
Fourth Quarter Fiscal Year 2025 – Segment Highlights
Senior
Revenue of $82.5 million
Adjusted EBITDA* of $7.7 million
Approved Medicare Advantage policies of 85,344
Healthcare Services
Revenue of $214.0 million
Adjusted EBITDA* of $11.9 million
108,018 SelectRx members
Life
Revenue of $48.0 million
Adjusted EBITDA* of $6.9 million
SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the fourth quarter of fiscal year 2025 of $345.1 million compared to consolidated revenue for the fourth quarter of fiscal year 2024 of $307.2 million. Consolidated net income for the fourth quarter of fiscal year 2025 was $12.9 million compared to consolidated net loss for the fourth quarter of fiscal year 2024 of $31.0 million. Finally, consolidated Adjusted EBITDA* for the fourth quarter of fiscal year 2025 was $2.7 million compared to consolidated Adjusted EBITDA* for the fourth quarter of fiscal year 2024 of $14.4 million.
Tim Danker, SelectQuote Chief Executive Officer, commented “The strength of our holistic healthcare services model was broadly exhibited in fiscal 2025, and we firmly believe the years ahead will increasingly drive substantial value for each of our stakeholders. Policyholders and patients will continue to benefit from our information advantage through tailored advice and healthcare solutions, which ultimately result in better health outcomes. Our insurance and healthcare service partners benefit from better treatment fit and adherence, which eliminates waste and serves to ease the historical trend of rising healthcare costs for Americans. Additionally, we believe our shareholders will benefit as SelectQuote’s diverse breadth of revenues drive increasing cash flow, which will accelerate and compound with new growth initiatives in the future.”
Mr. Danker continued, “We are proud to have delivered financial results well in excess of our initial expectations for the 3rd consecutive year. Over that period, our Adjusted EBITDA results have outperformed our forecasts by more than 20% each year. Our leadership and workforce have accomplished these results through significant change in Medicare Advantage in each year. We credit the talent and hard work of our people and are exceedingly proud of the track record SelectQuote has built as an agile, innovative and reliable source of value for Americans seeking healthcare that best fits their needs.”
* See “Non-GAAP Financial Measures” below.
Segment Results
We currently have three reportable segments: 1) Senior, 2) Healthcare Services and 3) Life. The performance measures of the segments include total revenue and Adjusted EBITDA.* Costs of commissions and other services revenue, cost of goods sold-pharmacy revenue, marketing and advertising, selling, general, and administrative, and technical development operating expenses that are directly attributable to a segment are reported within the applicable segment. Indirect costs of revenue, marketing and advertising, selling, general, and administrative, and technical development operating expenses are allocated to each segment based on varying metrics such as headcount. Adjusted EBITDA is our segment profit measure to evaluate the operating performance of our business. We define Adjusted EBITDA as income (loss) before income tax expense (benefit) plus: (i) interest expense, net; (ii) depreciation and amortization; (iii) share-based compensation; (iv) goodwill, long-lived asset, and intangible assets impairments; (v) transaction costs; (vi) loss on disposal of property, equipment and software, net; (vii) other non-recurring expenses and income; (viii) changes in fair value of warrant liabilities. Adjusted EBITDA margin is calculated as Adjusted EBITDA divided by revenue.
Senior
Financial Results
The following table provides the financial results for the Senior segment for the periods presented:
Operating Metrics
Submitted Policies
Submitted policies are counted when an individual completes an application with our licensed agent and provides authorization to the agent to submit the application to the insurance carrier partner. The applicant may have additional actions to take before the application will be reviewed by the insurance carrier.
The following table shows the number of submitted policies for the periods presented:
Approved Policies
Approved policies represents the number of submitted policies that were approved by our insurance carrier partners for the identified product during the indicated period. Not all approved policies will go in force.
The following table shows the number of approved policies for the periods presented:
Lifetime Value of Commissions per Approved Policy
Lifetime value of commissions per approved policy represents commissions estimated to be collected over the estimated life of an approved policy based on multiple factors, including but not limited to, contracted commission rates, carrier mix and expected policy persistency with applied constraints. The lifetime value of commissions per approved policy is equal to the sum of the commission revenue due upon the initial sale of a policy, and when applicable, an estimate of future renewal commissions.
The following table shows the lifetime value of commissions per approved policy for the periods presented:
Healthcare Services
Financial Results
The following table provides the financial results for the Healthcare Services segment for the periods presented:
Operating Metrics
Members
The total number of SelectRx members represents the amount of active customers to which an order has been shipped and the prescriptions per day represents the total average prescriptions shipped per business day. These two metrics are the primary drivers of revenue for Healthcare Services.
* See “Non-GAAP Financial Measures” below.
The following table shows the total number of SelectRx members as of the periods presented:
The total number of SelectRx members increased by 31% as of June 30, 2025, compared to June 30, 2024, due to our strategy to grow SelectRx membership.
The following table shows the average prescriptions shipped per day for the periods presented:
Combined Senior and Healthcare Services – Consumer Per Unit Economics
Combined Senior and Healthcare Services consumer per unit economics represents total MA and MS commissions; other product commissions; other revenues, including revenues from Healthcare Services; and operating expenses associated with Senior and Healthcare Services, each shown per number of approved MA and MS policies over a given time period. Management assesses the business on a per-unit basis to help ensure that the revenue opportunity associated with a successful policy sale is attractive relative to the marketing acquisition cost. Because not all acquired leads result in a successful policy sale, all per-policy metrics are based on approved policies, which is the measure that triggers revenue recognition.
The MA and MS commission per MA/MS policy represents the LTV for policies sold in the period. Other commission per MA/MS policy represents the LTV for other products sold in the period, including DVH prescription drug plan, and other products, which management views as additional commission revenue on our agents’ core function of MA/MS policy sales. Pharmacy revenue per MA/MS policy represents revenue from SelectRx, and other revenue per MA/MS policy represents revenue from Population Health, production bonuses, marketing development funds, lead generation revenue, and adjustments from the Company’s reassessment of its cohorts’ transaction prices. Total operating expenses per MA/MS policy represents all of the operating expenses within Senior and Healthcare Services. The revenue to customer acquisition cost (“CAC”) multiple represents total revenue as a multiple of total marketing acquisition cost, which represents the direct costs of acquiring leads. These costs are included in marketing and advertising expense within the total operating expenses per MA/MS policy.
The following table shows combined Senior and Healthcare Services consumer per unit economics for the periods presented. Based on the seasonality of Senior and the fluctuations between quarters, we believe that the most relevant view of per unit economics is on a rolling 12-month basis. All per MA/MS policy metrics below are based on the sum of approved MA/MS policies, as both products have similar commission profiles.
Total revenue per MA/MS policy increased 22% for the twelve months ended June 30, 2025, compared to the twelve months ended June 30, 2024, primarily due to the increase in pharmacy revenue. Total operating expenses per MA/MS policy increased 27% for the twelve months ended June 30, 2025, compared to the twelve months ended June 30, 2024, driven by an increase in cost of goods sold-pharmacy revenue for Healthcare Services due to the growth of the business.
Life
Financial Results
The following table provides the financial results for the Life segment for the periods presented:
Operating Metrics
Life premium represents the total premium value for all policies that were approved by the relevant insurance carrier partner and for which the policy document was sent to the policyholder and payment information was received by the relevant insurance carrier partner during the indicated period. Because our commissions are earned based on a percentage of total premium, total premium volume for a given period is the key driver of revenue for our Life segment.
The following table shows term and final expense premiums for the periods presented:
Earnings Conference Call
SelectQuote, Inc. will host a conference call with the investment community on August 21, 2025, beginning at 8:30 a.m. ET. To register for this conference call, please use this link: https://registrations.events/direct/Q4I547808. After registering, a confirmation will be sent via email, including dial-in details and unique conference call codes for entry. Registration is open through the live call, but to ensure you are connected for the full call we suggest registering at least 10 minutes before the start of the call. The event will also be webcasted live via our investor relations website https://ir.selectquote.com/investor-home/default.aspx.
Non-GAAP Financial Measures
This release includes certain non-GAAP financial measures intended to supplement, not substitute for, comparable GAAP measures. To supplement our financial statements presented in accordance with GAAP and to provide investors with additional information regarding our GAAP financial results, we have presented in this release Adjusted EBITDA, which is a non-GAAP financial measure. This non-GAAP financial measure is not based on any standardized methodology prescribed by GAAP and is not necessarily comparable to any similarly titled measure presented by other companies. We define Adjusted EBITDA as net income (loss) before income tax expense (benefit), plus interest expense, depreciation and amortization, changes in fair value of warrant liabilities, and certain add-backs for non-cash or non-recurring expenses, including restructuring and share-based compensation expenses. The most directly comparable GAAP measure is net income (loss) before income tax expense (benefit). We monitor and have presented in this release Adjusted EBITDA because it is a key measure used by our management and Board of Directors to understand and evaluate our operating performance, establish budgets, and develop operational goals for managing our business. In particular, we believe that excluding the impact of these expenses in calculating Adjusted EBITDA can provide a useful measure for period-to-period comparisons of our core operating performance.
Reconciliations of net income (loss) before income tax expense (benefit) to Adjusted EBITDA are presented below beginning on page 12. The Company is unable to provide a quantitative reconciliation of forward-looking Adjusted EBITDA to its most directly comparable GAAP measure without unreasonable effort because it is not possible to predict certain information included in the calculation of such GAAP measure, including the fair value of outstanding warrants to purchase shares of the Company’s common stock. The unavailable information could have a significant impact on the Company’s GAAP financial results.
Forward Looking Statements
This release contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as “may,” “should,” “could,” “predict,” “potential,” “believe,” “will likely result,” “expect,” “continue,” “will,” “anticipate,” “seek,” “estimate,” “intend,” “plan,” “projection,” “would” and “outlook,” or the negative version of those words or other comparable words or phrases of a future or forward-looking nature. These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about our industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements.
There are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the following: our reliance on a limited number of insurance carrier partners and any potential termination of those relationships or failure to develop new relationships; existing and future laws and regulations affecting the health insurance market; changes in health insurance products offered by our insurance carrier partners and the health insurance market generally; insurance carriers offering products and services directly to consumers; changes to commissions paid by insurance carriers and underwriting practices; competition with brokers, exclusively online brokers and carriers who opt to sell policies directly to consumers; competition from government-run health insurance exchanges; developments in the U.S. health insurance system; our dependence on revenue from carriers in our senior segment and downturns in the senior health as well as life, automotive and home insurance industries; our ability to develop new offerings and penetrate new vertical markets; risks from third-party products; failure to enroll individuals during the Medicare annual enrollment period; our ability to attract, integrate and retain qualified personnel; our dependence on lead providers and ability to compete for leads; failure to obtain and/or convert sales leads to actual sales of insurance policies; access to data from consumers and insurance carriers; accuracy of information provided from and to consumers during the insurance shopping process; cost-effective advertisement through internet search engines; ability to contact consumers and market products by telephone; global economic conditions, including inflation and tariffs; disruption to operations as a result of future acquisitions; significant estimates and assumptions in the preparation of our financial statements; impairment of goodwill; existing or potential litigation and other legal proceedings or inquiries, including the Department of Justice action alleging violations of the federal False Claims Act; our existing and future indebtedness; our ability to maintain compliance with our debt covenants; access to additional capital; failure to protect our intellectual property and our brand; fluctuations in our financial results caused by seasonality; accuracy and timeliness of commissions reports from insurance carriers; timing of insurance carriers’ approval and payment practices; factors that impact our estimate of the constrained lifetime value of commissions per policyholder; changes in accounting rules, tax legislation and other legislation; disruptions or failures of our technological infrastructure and platform; failure to maintain relationships with third-party service providers; cybersecurity breaches or other attacks involving our systems or those of our insurance carrier partners or third-party service providers; our ability to protect consumer information and other data; failure to market and sell Medicare plans effectively or in compliance with laws; and other factors related to our pharmacy business, including manufacturing or supply chain disruptions, access to and demand for prescription drugs, contractual reimbursement rates, and regulatory changes or other industry developments that may affect our pharmacy operations. For a further discussion of these and other risk factors that could impact our future results and performance, see the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025 (the “Annual Report”) and subsequent periodic reports filed by us with the Securities and Exchange Commission. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise..
About SelectQuote:
Founded in 1985, SelectQuote (NYSE: SLQT) pioneered the model of providing unbiased comparisons from multiple, highly-rated insurance companies, allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin SelectQuote’s success: a strong force of highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources and routes high-quality leads. Today, the Company operates an ecosystem offering high touchpoints for consumers across insurance, pharmacy, and virtual care.
With an ecosystem offering engagement points for consumers across insurance, Medicare, pharmacy, and value-based care, the company now has three core business lines: SelectQuote Senior, SelectQuote Healthcare Services, and SelectQuote Life. SelectQuote Senior serves the needs of a demographic that sees around 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. SelectQuote Healthcare Services is comprised of the SelectRx Pharmacy, a Patient-Centered Pharmacy Home™ (PCPH) accredited pharmacy, SelectPatient Management, a provider of chronic care management services, and Healthcare Select which proactively connects consumers with a wide breadth of healthcare services supporting their needs.
